Skip to main content
Mahasweta Gooptu, MD, Oncology, Boston, MA

MahaswetaGooptuMD

Oncology Boston, MA

Hematologic Oncology

Instructor, Medical Oncology, Jefferson Medical College-Thos Jefferson Univ

Dr. Gooptu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gooptu's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215
    Phone+1 617-632-6000

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2009 - 2012
  • Medical College and Hospital Kolkata
    Medical College and Hospital KolkataClass of 2007

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • MA State Medical License
    MA State Medical License 2016 - 2026
  • RI State Medical License
    RI State Medical License 2022 - 2026
  • PA State Medical License
    PA State Medical License 2009 - 2016
  • MO State Medical License
    MO State Medical License 2012 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation
    Mahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Mahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease
    Mahasweta Gooptu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Importance of Donor HLA Matching Confirmed, but Research Highlights Health Disparity
    Importance of Donor HLA Matching Confirmed, but Research Highlights Health DisparityAugust 31st, 2021